Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 6/20 | 0.32 |
| ▸ | PRKCA | P17252 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24326021 | 0.83 | CYP1A2 (0.42) | CYP1A2CA1CA9PRKCATP53 | |
| SCHEMBL26360493 | 0.79 | CYP1A2 (0.45) | CYP1A2CA1CA9PRKCATP53 | |
| SCHEMBL13267002 | 0.76 | CYP1A2 (0.43) | CYP1A2CA1CA9PRKCA | |
| SCHEMBL686098 | 0.76 | CYP1A2 (0.40) | CYP1A2CA1CA9GRM2PRKCA | |
| SCHEMBL6721695 | 0.75 | CYP1A2 (0.38) | CYP1A2CA1CA9TP53CYP3A4 | |
| SCHEMBL9694969 | 0.75 | CYP1A2 (0.41) | CYP1A2CA1CA9PRKCA | |
| SCHEMBL10172891 | 0.75 | RECQL (0.36) | CYP1A2PRKCA | |
| SCHEMBL445031 | 0.74 | ALDH1A1 (0.58) | CYP1A2CA1CA9PRKCATP53 | |
| SCHEMBL26356325 | 0.74 | CYP1A2 (0.41) | CYP1A2CA1CA9PRKCA | |
| SCHEMBL686466 | 0.74 | CYP1A2 (0.35) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110091808-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091808-A1 | PHOTORESIST COMPOSITION | ASIC1, ASIC3, SUN2 | CYP1A2 3633/4885CA1 597/4885CA9 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.